Reducing Health Disparities

Share

Cancer impacts everyone, but it doesn’t impact everyone equally. We are working to ensure everyone has a fair and just opportunity to prevent, find, treat, and survive cancer. No one should be disadvantaged in their fight against cancer because of how much money they make, the color of their skin, their sexual orientation, their gender identity, their disability status, or where they live.

From ensuring greater diversity among clinical trial participants to improving access to quality, affordable health care, we are asking lawmakers to reduce disparities in cancer care by advancing policies that break down existing barriers.

Black women are 40% more likely to die of breast cancer than white women overall

Latest Updates

November 15, 2021
National

More than 150 organizations representing patients, providers and health equity advocates sent a letter to Congress today urging them to pass the Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act into law.

November 2, 2021
New York

Gov Hochul has enacted a measure that will increase the list of vaccines a pharmacist may administer.

October 29, 2021
Louisiana

BATON ROUGE, LA - Yesterday, the American Cancer Society Cancer Action Network (ACS CAN) hosted a policy forum addressing health disparities and its impact on access to care for cancer patients and survivors. The panel discussion included key stakeholders throughout the health community and two elected officials, Sen. Fred Mills

October 28, 2021
National

A new survey shows cancer patients and recent survivors have had a positive experience using telehealth in the wake of the pandemic and are willing to use or adapt to using telehealth services in the future.

Reducing Health Disparities Resources

ACS CAN and more than 150 organizations representing patients, providers and health equity advocates sent a letter to Congress urging them to pass the Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act into law to remove barriers to clinical trial enrollment.

For 30 years, the Centers for Disease Control and Prevention’s National Breast and Cervical Cancer Early Detection Program has decreased disparities in breast and cervical cancer deaths.

Cancer biomarker testing can lead to targeted therapy which can improve survival and quality of life by connecting patients to the most beneficial treatment for their disease.